Welcome to SCILIV
Research and clinical practice at the intersection of osteoporosis and implants are critical for improving the outcomes of implant procedures in osteoporotic patients. Advances in biomaterials, biological enhancements, pharmacology, and implant design hold promise for addressing the unique challenges posed by osteoporotic bone, ultimately leading to better integration, stability, and overall success of implants.
Here’s a comprehensive overview of the intersection between osteoporosis and implants, focusing on research areas, challenges, and strategies to improve outcomes.
SCILIV, with its integrated Contract Research Organization and Live R&D Centre, offers a comprehensive suite of services that support the pharmaceutical, biotechnology, and medical device industries in developing new products. By leveraging their expertise, advanced technology, and collaborative approach, SCILIV helps clients navigate the complexities of drug development, ensuring efficient, cost-effective, and compliant pathways from research to commercialization